Hefei Tuosheng Pharmaceutical Technology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hefei Tuosheng Pharmaceutical Technology Co., Ltd. - overview
Established
2025
Location
Hefei, Anhui, China
Primary Industry
Biotechnology
About
Based in Hefei, China and founded in 2025, Hefei Tuosheng Pharmaceutical Technology Co. , Ltd. is a biopharmaceutical company operating in the field of innovative oncology therapies. In January 2026, Hefei Tuosheng Pharmaceutical Technology Co.
, Ltd. closed Pre-A funding from new investors Feixi Urban and Rural Construction Investment and Hainan New Haofei. Hefei Tuosheng Pharmaceutical Technology Co. , Ltd.
primarily focuses on the research and development of third-generation antibody-drug conjugates (ADCs), concentrating on innovative research and development design of multi-target and differentiated payloads and oncology pipeline development. The company generates revenue from developing antibody-drug conjugates and other biopharmaceutical products.
Current Investors
Jiadao Private Capital, Together To Miracle, Hefei State-Owned Assets Holding
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.